Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced a distribution partnership to expand access to Akadeum's next-generation cell isolation technology for cell and gene therapy development. Under the agreement, …
Synaffix B.V., a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with potential best-in-class therapeutic index, today jointly announced that it has entered into a licensing agreement with Qurient Co., Ltd., a clinical-stage biophar…
Aquavit Pharmaceuticals AG announced the successful acquisition and integration of Axon Technologies AG, formerly known as Genève Technologies, marking a strategic leap forward in artificial intelligence (AI) and advanced life-science innovation. “By bringing Axon Technologies into the Aquavit family, we fuse world-c…
Merck, a leading science and technology company, and Siemens, a leading technology company, signed a new Memorandum of Understanding (MoU), extending their strategic partnership to accelerate digital transformation in the life science industry. The MoU focuses on delivering integrated software solutions, systems and c…
LabConnect, a leading provider of global central laboratory and support services for clinical trials, announces a strategic collaboration with The Bracken Group to enhance its radiopharmaceutical support capabilities. As demand for radiopharmaceutical expertise continues to surge, with industry growth estimated betwe…
GCCL (Global Clinical Central Lab), a South Korea-based leading provider of clinical trial sample analysis, and Frontage Laboratories, Inc., a USA based full-service contract research organization (CRO), announced that they had signed a strategic Memorandum of Understanding (MOU) pursuant to which they intend to explo…
SOPHiA GENETICS, an AI technology company transforming precision medicine, announced an expansion of its collaboration with AstraZeneca from the World CB & CDx Summit in Boston. The companies aim to improve the diagnosis and treatment of breast and prostate cancer by developing an optimized next generation sequenc…
Roche announced that it has entered into a definitive merger agreement to acquire 89bio, Inc., a publicly listed clinical-stage biopharmaceutical company pioneering the development of innovative therapies for the treatment of liver and cardiometabolic diseases. This acquisition underscores Roche’s dedication to advan…
Biogen Inc. announced the company has entered into a definitive agreement to acquire Massachusetts-based Alcyone Therapeutics. As part of an existing partnership with Alcyone Therapeutics, the companies are advancing ThecaFlex DRx™, an implantable subcutaneous port and catheter device being investigated for the intrat…
FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization for biologics, vaccines, and advanced therapies, announced a significant expansion of its global partnership with argenx SE, a global immunology company. As part of the expanded agreement, FUJIFILM Biotechnologies will initia…
Page 34 of 43